baber/WOPTO huggingface dataset:
Patent CA-2353016-A1 (CA)
Inventor: WANG GANG
IPC: G16H10/60
Filed: 2001-07-12
Abstract: A method and apparatus for retrieving, accessing, and storing medical data relating to a patient during a medical procedure. The invention provides a single interface to many disparate forms of medical data, which is accessible over a local area network, wide area network, direct connection, or combinations thereof.  In one embodiment, an operating room control system for use during a medical procedure on a patient includes an input device, a display device, and a controller that is coupled to the input device and the display device. The controller receives one or more user inputs, transmits a command to a server located outside of the operating room to retrieve medical data, receives the medical data from the server, and displays the medical data on the display device. Medical data can be captured by the controller using, for example, a camera and a video/ image capture board, keyboard, and microphone during surgery or examination of the patient. The captured medical data can be stored on one or more remote servers as part of the patient records.
Patent CA-2354306-A1 (CA)
Title: Plastic recycling
Inventor: BERGERON CLAUDE
IPC: C08J11/08
Filed: 2001-07-27
Abstract: There is provided a method for recovering energy from glass windshields removed from vehicles which comprises the step of separating a polyvinyl butyral polymer from the glass in a windshield and using the recovered polyvinyl butyral polymer as a fuel to replace a fossil fuel in an energy creating plant or alternatively to use th e polyvinyl butyral polymer as an adhesive.
Patent CA-2355010-A1 (CA)
Inventor: WHITSON ROBERT L
IPC: E02D29/02
Filed: 2001-08-10
Abstract: The present invention relates to an interlocking masonry wall block having an open core and spaced projections that enable stacked blocks to be interlocked, setback and staggered to form a stable gravity-type retaining wall that is particularly suited for landscaping applications. The open core extends completely through the block from top to bottom. The block is formed by front, rear and opposed side walls, each having parallel inside and outside surfaces. One projection extends from the lower surface of each side wall. The front of each projection is forward the inside surface of the front wall to provide the setback when stacked on other like-shaped blocks. Each block is stacked in a staggered manner atop two other blocks. One projection of each block is received by the open core of one of the two lower blocks. The projections abut the inside surface of the front wall of the lower blocks to interlock the blocks together. The block has a preferably trapezoidal shape with a wider front wall to help accommodate the formation of serpentine walls. The block can be used to make serpentine walls with straight and curved portions with a relatively constant pitch.
Patent CA-2356261-A1 (CA)
Inventor: SPRINGS MARC A
IPC: C08F4/64
Filed: 1999-12-06
Abstract: La présente invention concerne un procédé de préparation d'un catalyseur de polymérisation oléfinique, ce procédé consistant tout d'abord à mettre en présence un support de silice calciné et passivé (précurseur de support) et une première solution d'un complexe métallique ou d'un co-catalyseur, et ce à plusieurs reprises. Ce procédé consiste ensuite à mettre en présence ce support et une seconde solution du complexe métallique ou du co-catalyseur, selon que l'un ou l'autre a été utilisé dans l'étape précédente, cette seconde solution étant présente dans une quantité permettant de ne pas dépasser 100 pour cent du volume des pores du précurseur de support. De plus, ce procédé peut éventuellement consister à éliminer le solvant compatible de la première et/ou de la seconde solution. La présente invention concerne également un procédé de polymérisation d'une ou plusieurs alpha-oléfines en présence d'un catalyseur de polymérisation oléfinique, préparé selon le procédé susmentionné.
Patent CA-2356774-A1 (CA)
Inventor: PAOLINI FRANCESCO
IPC: A61M1/16
Filed: 2000-11-02
Abstract: A method for preparing a medical liquid from a liquid, such as water, and two concentrated solutions comprises the following steps: circulating the liquid in a conduit ( 15 ), at a flowrate Q 0; injecting into the conduit ( 15 ), at a flowrate Q 1 , a first concentrated solution containing a first ionic substance A and a second ionic substance B, the ionic substances A and B having, respectively, in the first concentrated solution, a concentration [Asol] and a first concentration [B 1 sol]; injecting into the conduit ( 15 ), at a flowrate Q 2 , a second concentrated solution containing the first ionic substance A and the second ionic substance B, the first ionic substance A having, in the second concentrated solution, the same concentration [Asol] as in the first concentrated solution, and the second ionic substance B having, in the second concentrated solution, a second concentration [B 2 sol] different than the first concentration [B 1 sol] in the first concentrated solution; regulating the injection flowrate Q 1 and the injection flowrate Q 2 of the first and second concentrated solutions in such a way that at any given time the diluted solution resulting from the mixing of the liquid and the concentrated solutions has a desired concentration [Ades] of first substance A and a desired concentration [Bdes] of second substance B.
Patent CA-2358862-A1 (CA)
Title: Methods of increasing lean tissue mass using ob protein compositions
Inventor: PELLEYMOUNTER MARY ANN
IPC: C07K19/00
Filed: 1996-11-04
Abstract: Methods of using OB protein compositions for increasing lean tissue mass are provided. Also provided are methods of using OB protein compositions for increasing insulin sensitivity, as well as increasing overall body strength and decreasing bone resorption.
Patent CA-2360650-A1 (CA)
Title: Algorithm to create and compare debug scenarios of a computer process
Inventor: BATES CARY L
IPC: G06F11/36
Filed: 2001-10-31
Abstract: A computer program debugger is disclosed which stores previous programs which have been debugged and the debug parameters which were considered when debugging. When a new computer program is to be debugged, the new debugger is invoked and it automatically compares the executing program to be debugged with the previous programs. When one or more of the debug parameters are so similar that it can be said that the computer program undergoing debugging matches a previously stored computer program, a user is given options to display the matching programs, the modules, the functions, the lines, and the debug parameters and to exchange debug parameters between the programs which can be used to modify the either or any of the programs. The user is further given the option to store the current program undergoing debugging as a new program to be considered in matching the next program to be debugged. It is further envisioned that the various debug scenarios may be stored and can be recalled separately from the program that generates or uses them.
Patent CA-2365396-A1 (CA)
Inventor: JACKSON ADAM
IPC: G06F17/30
Filed: 2000-02-29
Abstract: Context data processing is described herein. One or more contexts are selected. Each context includes one or more attributes, and a plurality of data objects that satisfy the attributes. A list of data objects contained in the selected contexts is displayed. At least some of the data objects in the selected contexts are processed. Such processing may involve generating claim trees, citation trees, and data object families, which may be displayed using hyperbolic trees. In an embodiment, the contexts are groups. In other embodiment, the contexts are each associated with a data object type. In this latter embodiment, the contexts include data objects of their respective data object types.
Patent CA-2367758-A1 (CA)
Inventor: DESPRE DENIS
IPC: A23L7/10
Filed: 2000-03-30
Abstract: The present invention relates to full waxy wheat products, especially full waxy wheat flours that are thermally treated or not, full waxy wheat starch, in addition to methods for the production thereof. The invention also relates to the uses of said products, especially in the production of food products or non-food products.
Patent CA-2368661-A1 (CA)
Title: Juices incorporating early season orange cultivars
Inventor: TAGGART THOMAS
IPC: A23L2/06
Filed: 2000-05-09
Abstract: Orange juice is provided which includes as a component juice extracted from a very early season round orange cultivar which is not a Hamlin cultivar. The juice extracted from such very early season cultivar has sensory attributes which are superior to those of Hamlin fresh juice. The very early season jui ce has a Brix-to-acid ratio and a color intensity in excess of those provided b y Hamlin cultivars which are harvested at the same time as the very early seas on cultivar. Preferred very early season cultivars are within the Seleta family  or are Westin cultivars or are Ruby Nucellar cultivars.
Patent CA-2371150-A1 (CA)
Title: Lanthanum nickel compound/metal mixture as a third electrode in a metal-air battery
Inventor: ZHONG ZHIMIN
IPC: H01M4/90
Filed: 2000-04-20
Abstract: The present invention relates to a third electrode (104) for use in a metal- air tricell (100, 200) comprising a support structure coated with a layer of  a lanthanum nickel compound/at least one metal mixture, wherein the mixture is  adhered to the support structure without the use of an adhesive. The present  invention relates to a metal-air tricell comprising an air electrode (102), a metal electrode (106), and the third electrode (104). Additionally, the present invention relates to a method of forming a third electrode, comprisi ng the steps of: a) applying a mixture of a lanthanum nickel compound and at least one metal oxide to a support structure, and b) heating the coated support structure in order to reduce the metal oxide present in the lanthanu m nickel compound/metal oxide mixture to its corresponding metal and to adhere  the lanthanum nickel compound/metal mixture to the support structure.</SDOAB >
Patent CA-2372161-A1 (CA)
Title: Dispenser with temperature indicating means
Inventor: DEAN MICHAEL
IPC: B29B7/74
Filed: 2000-05-02
Abstract: An improved fluent product dispensing apparatus (10) is disclosed and includes a temperature indicator (50) so that the user may view the temperature of the fluent product component prior to and during dispensing. The apparatus includes one or more supply containers (81, 82) of a reactive component, a dispenser (90) and a conduit (86, 87) for conveying the reactive components to the dispenser. One or more of the supply containers has a temperature indicator (50) mounted to its exterior that is viewable through a package, or carton (100), that encloses the supply containers. This indicator displays the temperature of the contents of the supply container so that a user can ensure proper dispensing of the reactive components.
Patent CA-2372201-A1 (CA)
Inventor: GAISER JOHN
IPC: A61B18/12
Filed: 2000-05-02
Abstract: L'invention concerne des systèmes et des méthodes intégrant la régulation d'un générateur d'énergie (38), pour alimenter en énergie une structure d'électrode afin de chauffer une région tissulaire, et le réglage d'un mécanisme de pompage (44), pour alimenter en fluide de refroidissement ladite région afin de réguler la température des tissus.
Patent CA-2372738-A1 (CA)
Inventor: KLASSEN HENRY
IPC: A61P27/02
Filed: 2000-05-08
Abstract: La présente invention se rapporte à l'administration de faibles doses d'interleukine IL-1.beta., inférieures ou égales à 50 µg/ml et de préférence inférieures ou égales à 10 g$(m)g/ml, qui peut encore induire une récupération de cellules neuronales telles que les cellules photoréceptrices, et n'entraîner qu'un minimum de séquelles destructrices, du type dysplasie rétinienne et inflammation intraoculaire.
Patent CA-2372768-A1 (CA)
Inventor: GRUBB GARY S
IPC: A61P15/08
Filed: 2000-05-01
Abstract: La présente invention concerne des thérapies combinatoires cycliques dans lesquelles sont utilisés des dérivés d'indoline qui sont des antagonistes du récepteur de progestérone, représentés par la structure générale (I) dans laquelle: A, B et D représentent N ou CH, mais ne peuvent pas tous représenter CH; R?1¿ et R?2¿ représentent H, COR?A¿, NR?B¿COR?A¿, ou des groupes alkyles, alcényles, alcynyles, cycloalkyles ou aryles éventuellement substitués; ou R?1¿ et R?2¿ forment un noyau spirocyclique; R?A¿ représente H ou aryle, alcoxy, aminoalkyle ou alkyle éventuellement substitué; R?B¿ représente H, alkyle; R?3¿ représente H, OH, NH¿2?, alkyle, alcényle, ou COR?C¿; R?C¿ représente H, alkyle, aryle, alcoxy, ou aminoalkyle; R?4¿ représente benzène ou un noyau hétéroaromatique contenant de 5 à 6 éléments; R?F¿ représente H, alkyle, aryle, alcoxy, ou aminoalkyle; R?G¿ représente H ou alkyle; R?5¿ représente H ou alkyle; W représente O ou une liaison chimique; ou un sel pharmaceutiquement acceptable. Lesdites méthodes peuvent être utilisées à des fins de contraception ou de traitement et/ou à des fins de prévention de l'aménorrhée secondaire, du saignement dysfonctionnel, du leiomyomata utérin, de l'endométriose, du syndrome des ovaires polykystiques, des carcinomes et des adénocarcinomes de l'endomètre, de l'ovaire, du sein, du colon ou de la prostate ou encore, pour réduire les effets secondaires ou les saignements menstruels cycliques. Lesdites méthodes peuvent également être utilisées pour stimuler l'ingestion alimentaire.
Patent CA-2372919-A1 (CA)
Inventor: MACHITTO KEVIN S
IPC: A61B18/20
Filed: 2000-05-17
Abstract: La présente invention concerne un procédé/système permettant la libération contrôlée à distance et locale de composés pharmaceutiques ou le recueil de biomolécules grâce à l'énergie électromagnétique. Les systèmes contrôlés à alimentation en énergie électromagnétique de l'invention sont intégrés dans des timbres adhésifs ou autres dispositifs de délivrance. L'invention se rapporte également à un timbre de délivrance de médicament ou de recueil de biomolécules surveillé électroniquement par un système de positionnement global.
Patent CA-2374627-A1 (CA)
Title: Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
Inventor: AHMAD SALEEM
IPC: C07D311/58
Filed: 2000-06-01
Abstract: A process is provided for preparing chiral cyclopropane carboxylic acids, preferably of structure (I) which are intermediates used in preparing acyl guanidine sodium/proton exchange (NHE) inhibitors.
Patent CA-2378418-A1 (CA)
Title: Process for the preparation of acetamide derivatives
Inventor: MENASHE NAIM
IPC: C07C323/60
Filed: 2002-03-22
Abstract: PROCESS FOR THE PREPARATION OF ACETAMIDE DERIVATIVES ABSTRACT OF THE DISCLOSURE The invention provides a process for the preparation of diphenylmethylthioacetamide (I) as described in Scheme 4 comprising reacting of the isothiouronium salt or its corresponding base of the formula IV with an acetamide of the formula XCH2CONH2, wherein X represents a halogen, M represents an alkali metal and A represents an anion, in a protic medium at a temperature of less than 100° C.
Patent CA-2381189-A1 (CA)
Inventor: YARBROUGH GRAHAM G
IPC: G06F15/16
Filed: 2001-06-01
Abstract: L'invention concerne un serveur de file d'attente de message émulant un périphérique informatique, lequel prend en charge une communication entre deux ordinateurs centraux et fournit une passerelle à des ordinateurs, systèmes ouverts, réseaux et autres serveurs similaires de file d'attente de messages. Le serveur de file d'attente de messages fournit une conversion de protocole à protocole à partir des ordinateurs centraux jusqu'aux systèmes de calcul actuels sans nécessité de recourir à des entreprises détentrices des ordinateurs centraux pour réécrire des applications patrimoniales en vue de partager des données avec d'autres ordinateurs centraux et systèmes ouverts. Le serveur de file d'attente de messages émule un périphérique d'ordinateur central couplé à un premier ordinateur central doté d'un premier protocole. Ledit système comprend au moins un gestionnaire qui (i) coordonne le transfert des informations du premier protocole entre l'émulateur périphérique d'ordinateur central et le dispositif de stockage numérique et (ii) coordonne le transfert des informations entre le dispositif de stockage numérique et (a) un second ordinateur central doté d'un deuxième protocole ou (b) un réseau informatique doté d'un troisième protocole. De préférence, le serveur de file d'attente de messages émule un entraînement de bande et agence les messages stockés dans une file d'attente. Le serveur de file d'attente de messages peut éventuellement gérer les files d'attente de messages en fonction d'informations habituellement présentes dans un label standard.
Patent CA-2383055-A1 (CA)
Title: An interactive television system
Inventor: DRAZIN JONATHAN
IPC: H04N7/173
Filed: 2000-08-29
Abstract: A system comprising a handset (18) that is operable to establish an audio telephonic link, a display for displaying video signals and controller (10) operable to communicate with the handset (18), the display and the controller (10) being separate from the handset (18). In use, the handset (18) is operable to send a response signal to the controller (10) in reply to a prompt on the display, which prompt is indicative of the availability of further information from a service provider, whereupon on receipt of the response signal, the controller (10) is operable to transmit a control signal to automatically cause an audio telephonic link between the handset (18) and the service provider to be established.
Patent CA-2383722-A1 (CA)
Title: A raman amplifier
Inventor: MASUM-THOMAS JOWAN
IPC: H04B10/17
Filed: 2002-04-26
Abstract: A Raman amplifier comprises first and second stages, in which a single pump source is used for both stages. The pump source output is coupled to one end of the second stage and unused pump power is tapped from the other end of the second stage.  The unused pump power is then introduced into the first stage. The attenuation of the pump source signal in the second stage results in a lower power pump signal being applied to the first stage. The specific design of the amplifier stages enables the two pump power levels to be suitable for different fiber types so that the advantages of a multi-stage amplifier are maintained (with each stage being designed taking into account the signal powers in the different stages) whilst simplifying the pump source requirements.
Patent CA-2384819-A1 (CA)
Inventor: LEVI NAIM
IPC: G01R33/30
Filed: 2000-09-12
Abstract: There is disclosed an NMR probe including a body defining an internal chambe r. This chamber is adapted for supporting a vacuum and the body is of a non- magnetic material. A conduit extends through the chamber in the body. The conduit has a first portion in communication with second portions, the first  portion being intermediate the second portions, with the first and second portions of non-magnetic materials with substantially equal thermal expansio n coefficients. An RF coil is positioned along at least a substantial portion of the first conduit portion. It is preferred that this device also include a field or frequency lock unit in the chamber, as well as a getter, to allow f or degassing in the chamber to maintain the preferred high pressure vacuum. A method of using this NMR probe for NMR analysis is also disclosed.
Patent CA-2385172-A1 (CA)
Inventor: EWALT KARLA L
IPC: A61K39/00
Filed: 2000-10-05
Abstract: A recombinant AB5 B subunit protein including at least one mutation, wherein  the mutation alters the number of amino acid residues available for chemical  modification as compared to a wild type AB5 B subunit protein, and wherein said recombinant protein retains an effective target ligand bind affinity. F or example, specifically designed mutations are produced in the cholera Toxin B  subunit (CTB) such that it can still bind with high affinity to its receptor , Gm-1, but can be specifically covalently linked at lysines or cysteines to a n immunogen or vaccine. The vaccine produced from this coupling is a mucosal vaccine which has high immunogenicity due to the interaction with the CTB. T he vaccine can be produced inexpensively and easily. Alternatively, a technique  is disclosed for treating CTB such that non-covalent coupling to a vaccine o r immunogen can occur.
Patent CA-2385519-A1 (CA)
Inventor: FIERKE JOHN R
IPC: H04N5/265
Filed: 2000-09-20
Abstract: Combining first (72) and second (74) video streams into a combined output video stream (78) by using a gradient table (90) listing gradient values for pixels in a video frame to address a look up table (62) of key values, and combining pixel values of the first and second video streams based upon respective key values read from the look up table (62).
Patent CA-2385528-A1 (CA)
Inventor: CHARI RAVI V J
IPC: A61P17/02
Filed: 2000-09-29
Abstract: La présente invention est fondée sur la découverte selon laquelle l'administration d'au moins un immunoconjugué et d'au moins un agent chimiothérapeutique à un patient offrent une traitement nettement amélioré du cancer. La présente invention concerne des compositions comprenant au moins un immunoconjugué et au moins un agent chimiothérapeutiques et des méthodes de traitement du cancer utilisant au moins un immunoconjugué et au moins un agent chimiothérapeutique. La présente invention concerne également des méthodes permettant de moduler la croissance de certaines populations cellulaires, telles que les cellules cancéreuses, consistant à administrer une quantité thérapeutiquement efficace d'au moins un agent chimiothérapeutique et au moins un immunoconjugué à un patient.
Patent CA-2386360-A1 (CA)
Title: Active ingredient combinations having insecticidal and acaricidal properties
Inventor: ERDELEN CHRISTOPH
IPC: A01N43/12
Filed: 2000-09-25
Abstract: The invention relates to insecticide and acaricide mixtures containing certain cyclic ketoenols and agonists or antagonists of nicotinergic acetylcholine receptors in order to protect plants from attack by pests.
Patent CA-2387865-A1 (CA)
Title: Electric vehicle and method for managing the same
Inventor: KASUGA NOBUYUKI
IPC: B60L11/18
Filed: 2000-10-12
Abstract: An electric vehicle (1) comprises a chargeable secondary cell (30), an electric motor (9) for driving the traveling parts such as wheels, and control means (5) for controlling the drive of the electric motor (9) by use of the power from the secondary cell (30). The electric vehicle further comprises clock means (7) for measuring the present time, wheel revolution detection means (10) for detecting the revolution of a wheel, and interface means (15) for storing vehicle management information created by the control means (5) from the information from the clock means (7) and the wheel revolution detection means (10) in a detachable external storage medium and for reading the stored information.